Bisphosphonates and osteonecrosis of the jaw.
Purcell
Patrick M
PM
Adverse Drug Reactions Unit, Therapeutic Goods Administration, Department of Health and Ageing, Canberra, ACT, Australia.
Boyd
Ian W
IW
D000284:Administration, Oral; D000328:Adult; D016907:Adverse Drug Reaction Reporting Systems; D000368:Aged; D000369:Aged, 80 and over; D020958:Australian Capital Territory; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary*; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008134:Long-Term Care; D008297:Male; D008336:Mandibular Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology; D008439:Maxillary Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology; D008875:Middle Aged; D010020:Osteonecrosis / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology
D004164:Diphosphonates